1. Home
  2. DXYZ vs AMRN Comparison

DXYZ vs AMRN Comparison

Compare DXYZ & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXYZ
  • AMRN
  • Stock Information
  • Founded
  • DXYZ N/A
  • AMRN 1989
  • Country
  • DXYZ
  • AMRN Ireland
  • Employees
  • DXYZ N/A
  • AMRN N/A
  • Industry
  • DXYZ
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • DXYZ
  • AMRN Health Care
  • Exchange
  • DXYZ Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • DXYZ 313.1M
  • AMRN 302.0M
  • IPO Year
  • DXYZ 2024
  • AMRN 1993
  • Fundamental
  • Price
  • DXYZ $23.60
  • AMRN $19.71
  • Analyst Decision
  • DXYZ
  • AMRN Strong Sell
  • Analyst Count
  • DXYZ 0
  • AMRN 1
  • Target Price
  • DXYZ N/A
  • AMRN $12.00
  • AVG Volume (30 Days)
  • DXYZ N/A
  • AMRN 109.1K
  • Earning Date
  • DXYZ N/A
  • AMRN 10-29-2025
  • Dividend Yield
  • DXYZ N/A
  • AMRN N/A
  • EPS Growth
  • DXYZ N/A
  • AMRN N/A
  • EPS
  • DXYZ N/A
  • AMRN N/A
  • Revenue
  • DXYZ N/A
  • AMRN $219,361,000.00
  • Revenue This Year
  • DXYZ N/A
  • AMRN N/A
  • Revenue Next Year
  • DXYZ N/A
  • AMRN N/A
  • P/E Ratio
  • DXYZ N/A
  • AMRN N/A
  • Revenue Growth
  • DXYZ N/A
  • AMRN N/A
  • 52 Week Low
  • DXYZ N/A
  • AMRN $7.08
  • 52 Week High
  • DXYZ N/A
  • AMRN $20.65
  • Technical
  • Relative Strength Index (RSI)
  • DXYZ 38.19
  • AMRN 66.31
  • Support Level
  • DXYZ $25.00
  • AMRN $19.25
  • Resistance Level
  • DXYZ $26.80
  • AMRN $20.64
  • Average True Range (ATR)
  • DXYZ 1.64
  • AMRN 1.09
  • MACD
  • DXYZ -0.20
  • AMRN 0.04
  • Stochastic Oscillator
  • DXYZ 7.52
  • AMRN 75.84

About DXYZ Destiny Tech100 Inc. Common Stock

Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: